"CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Spain" Published

GlobalData, the industry analysis specialist, has released its latest report, "CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Spain". The report is an essential source of information on and analysis of the healthcare, regulatory and reimbursement landscape in Spain. It identifies the key trends in the country's healthcare market, and provides insights into its demographic, regulatory, and reimbursement landscape and healthcare infrastructure. Most importantly, the report provides valuable insights into the trends and segmentation of the pharmaceutical and medical device markets. It uses data and information sourced from proprietary databases, secondary research, and in-house analysis by GlobalData's team of industry experts.

Full Report Details at
- http://www.fastmr.com/prod/977183_countryfocus_healthcare_regulatory_and.aspx?afid=301

Spain has strong healthcare infrastructure and the Spanish National Health System provides free healthcare for all citizens. In 2013, Spain spent approximately $17.4 billion on R&D, and exported approximately $13 billion of pharmaceuticals.

The pharmaceutical market was worth approximately $29 billion in 2008, and is projected to decline to approximately $22.6 billion by 2020, at a negative Compound Annual Growth Rate (CAGR) of 2.1%. The primary reasons for this decline are the austerity measures implemented by the Spanish government. The factors influencing the pharmaceutical market are -

* The increasingly elderly population
* Promotion of low-priced medicines
* Promotion of generics
* The medical device market was valued at $7.1 billion in 2008, and is projected to grow at a CAGR of 4.5% to an estimated $12 billion in 2020.

Scope

The report provides information on the healthcare, regulatory, and reimbursement landscape in Spain, and includes -

* An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers
* Profiles and SWOT analyses of the major players in the pharmaceutical market: Pfizer, Roche, Novartis, Sanofi and GlaxoSmithKline, as well as profiles and SWOT analyses of the major players in the medical device market: Siemens Healthcare, Roche, Medtronic, Abbott Laboratories and DePuy
* Insightful review of the reimbursement and regulatory landscape, with analysis covering details of the country's healthcare reimbursement process, regulatory agencies and the approval processes for new drugs and medical devices
* Detailed analysis of the political and economic environment, covering economic indicators, demographics, healthcare infrastructure and healthcare expenditure
* An overview of the opportunities for and challenges to growth in the healthcare market

Reasons to Get this Report

This report will enhance your decision-making capability by allowing you to -

* Develop business strategies by understanding the trends shaping and driving the Spanish healthcare market

About Fast Market Research

Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget.

For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156 (1.413.485.7001 Int'l)

You may also be interested in these related reports:

- CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Australia
- CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Mexico
- CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - South Africa
- CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Malaysia
- CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Israel